Transcriptomics

Dataset Information

0

In vivo transcriptome profiling of control and GANAB-KD UMUC3 bladder carcinoma cells [scRNA-Seq]


ABSTRACT: Carcinoma cells achieve malignant progression and therapy resistance through de-differentiation. While differentiation therapy has proven to be highly efficient in acute promyelocytic leukemia, this therapeutic strategy has not been successfully applied in human solid tumors. Here, we identify α-Glucosidase II (GANAB) as a novel driver of bladder cancer de-differentiation using a systemic biology approach and demonstrate its potential to serve as a therapeutic target of solid tumor differentiation therapy. Partial knock-out of GANAB by CRISPR Cas9 differentiates one of the most aggressive bladder carcinoma line into a non-invasive papillary form in vivo and decreases chemotherapy resistance in vitro. As differentiation and de-differentiation program are mostly activated in vivo, we labelled control and GANAB-KD cells with a lentivirus to express a H2B-EGFP localized in the nuclei. After sorting by BD FACS Aria II, cells were lyzed for RNA-sequencing.

ORGANISM(S): Homo sapiens

PROVIDER: GSE164041 | GEO | 2020/12/31

REPOSITORIES: GEO

Dataset's files

Source:
Action DRS
Other
Items per page:
1 - 1 of 1

Similar Datasets

2020-12-31 | GSE164042 | GEO
2015-09-26 | GSE73456 | GEO
2021-10-01 | GSE148824 | GEO
2020-11-11 | GSE146726 | GEO
| PRJNA688703 | ENA
2016-08-05 | E-GEOD-81157 | biostudies-arrayexpress
2021-05-18 | GSE164413 | GEO
2016-06-30 | E-GEOD-72686 | biostudies-arrayexpress
2017-05-13 | E-GEOD-57980 | biostudies-arrayexpress
2023-10-10 | MTBLS7252 | MetaboLights